NCT07058389

Brief Summary

Physical activity appears to be a novel and original adjunctive therapeutic approach in the management of patients with schizophrenia. It may help reduce schizophrenic symptoms, act as a pro-cognitive therapy, improve quality of life, and reduce cardiovascular comorbidities. Moreover, some evidence suggests that physical activity practiced in a natural environment has even more positive effects on mental health compared to physical activity carried out indoors or in urban settings. Indeed, greater exposure to greenery is associated with a better perception of general health and with reduced levels of cortisol, anxiety, and depression. No study has yet attempted to examine the impact of physical activity in green (outdoor) spaces compared to indoor physical activity on the negative symptoms of patients suffering from schizophrenia. The aim of this study is therefore to test this hypothesis.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
45

participants targeted

Target at P25-P50 for not_applicable

Timeline
18mo left

Started Oct 2025

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress29%
Oct 2025Dec 2027

First Submitted

Initial submission to the registry

June 30, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

July 10, 2025

Completed
3 months until next milestone

Study Start

First participant enrolled

October 7, 2025

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

November 25, 2025

Status Verified

November 1, 2025

Enrollment Period

1.6 years

First QC Date

June 30, 2025

Last Update Submit

November 20, 2025

Conditions

Keywords

Schizophrenia disordersMental healthQuality of lifePhysical fitness

Outcome Measures

Primary Outcomes (1)

  • Self-evaluation of negative symptoms (SNS) questionnaire

    The primary outcome will be the evolution of negative symtoms, assessed using the Self-evaluation of negative symptoms (SNS) questionnaire. The total SNS score ranges from 0 to 40, where higher scores indicate greater severity of negative symptoms.

    Weeks 2, 10 and 22

Secondary Outcomes (9)

  • Clinical global Impression (CGI) scale

    Weeks 2, 10 and 22

  • Personal and social performance (PSP) scale

    Weeks 2, 10 and 22

  • Subjective Scale to Investigate Cognition in Schizophrenia (SSTICS)

    Weeks 2, 10 and 22.

  • VO2 max

    Weeks 2, 10 and 22.

  • Maximum force

    Weeks 2, 10 and 22.

  • +4 more secondary outcomes

Study Arms (3)

INT group

EXPERIMENTAL

8-week indoor physical activity program (in a gymnasium)

Other: 8-week indoor physical activity program

EXT group

EXPERIMENTAL

8-week outdoor physical activity program

Other: 8-week outdoor physical activity program

TEM group

NO INTERVENTION

Without physical activiy program (no change in routine)

Interventions

EXT group will perform aerobic and resistance exercises with a coach in adapted physical activities on a green environment in a parc. Sessions will be typically composed as follows: * Warm-up (20 min) * Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale * Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale * Cool-down, stretching and balance (15 min) EXR group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.

EXT group

INT group will perform aerobic and resistance exercises with a coach in adapted physical activities, inside a conventional gym. Sessions will be typically composed as follows: * Warm-up (20 min) * Aerobic exercise (30 min) at RPE 4 to 7 on the Borg scale * Muscular strengthening (25 min) at RPE 4 to 7 on the Borg scale * Cool-down, stretching and balance (15 min) INT group will train for 8 weeks, twice a week for 1h30, following WHO recommendation.

INT group

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Patients with schizophrenia, aged 18 to 55 years
  • Having persistent negative symptoms (SNS), negative symptoms self-assessment scale \> 7
  • Regularly monitored in the psychiatry department.
  • Have no medical contraindications to physical activity
  • Subject affiliated with or entitled to a social security system.
  • Subject having received informed information about the study and having co-signed, with the investigator, consent to participate in the study.
  • Male or female.

You may not qualify if:

  • Patient unsuitable for study in the opinion of the investigator
  • Any subject with chronic joint pathologies (example: repeated sprains, patellar or ligament problems) or cardiac pathologies.
  • Any subject presenting chronic or central neurological pathologies.
  • Any subject deprived of liberty or subject to legal protection
  • Excessive consumption of alcohol (\> 14 glasses per week) or caffeinated drinks (\> 400 mg of coffee per day).
  • Pregnant women.
  • Subject unable to understand the purpose and conditions of the study, unable to give consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHU de Saint-Etienne

Saint-Etienne, France, 42055, France

RECRUITING

MeSH Terms

Conditions

Psychotic DisordersSchizophreniaPsychological Well-Being

Condition Hierarchy (Ancestors)

Schizophrenia Spectrum and Other Psychotic DisordersMental DisordersPersonal SatisfactionBehavior

Study Officials

  • Medhi HOUSNI, Md

    CHU de Saint-Etienne

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 30, 2025

First Posted

July 10, 2025

Study Start

October 7, 2025

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

November 25, 2025

Record last verified: 2025-11

Data Sharing

IPD Sharing
Will not share

Locations